USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark TRIPATH ONCOLOGY was filed as Word mark on 06/24/2002 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word mark |
| File reference | 76423903 |
| Application date | June 24, 2002 |
| Publication date | July 15, 2003 |
Trademark owner
HA155
95054 SANTA CLARA
US
95054 SANTA CLARA
US
Trademark representatives
goods and services
1
Diagnostic assay kits containing nucleic acid for research use in providing genomic and proteomic profiles useful in the selection of therapeutics for clinical medical use, diagnostic assay kits containing antibody reagents for research use in providing genomic and proteomic profiles useful in the selection of therapeutics for clinical medical use
5
Diagnostic assay kits containing nucleic acid for diagnosing cancer, diagnostic assay kits containing antibody reagents for diagnosing cancer, diagnostic assays for diagnostic and therapeutic clinical medical use, and prescription pharmaceuticals for use in the diagnosis or treatment of human diseases, namely cancer
9
Computer programs for use in cancer research namely, the analysis, data management, and data visualization of nucleic acid sequences and amino acid sequences, and for use in the identification and characterization of genes and proteins and computer programs for use in the management, storage, retrieval and analysis of data used in the discovery and development of diagnostic, prognostic, and therapeutic medical products for the treatment of cancer
42
Research services, namely, research, development, validation, testing, data analysis and product development services in the field of cancer; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the field of cancer
44
Medical and diagnostic services, namely, diagnosing, preventing, and predicting cancer, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing cancer treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; consultation services, namely, providing consultation to others via global, national, and local computer network in the field of cancer; and providing on-line computer databases via global, national, and local computer networks in the field of cancer
ID: 1376423903